Mediso Medical Imaging Systems Ltd.
Mediso is active in nuclear medicine since 1990 with a profile of development, manufacturing, selling and servicing molecular imaging multi-modality devices. The company offers complete solutions from hardware to evaluation and quantification software both for clinical patient care and scientific research. Beside a unique 3-modality clinical SPECT-CT-PET hybrid system, Mediso launched its new AnyScan TRIO, TRIPLE head SPECT combination system with CT-PET option. The nanoScan small animal imager family consist of SPECT-MRI, PET-MRI, SPECT-CT and PET-CT products. Mediso runs two complex clinical diagnostic, research and teaching centers and offers clinical and evaluation software trainings for the international medical community.